Showing 8771-8780 of 20877 results for "".
Revolutionizing Aesthetic Medicine and Dermatology with Artificial Intelligence
https://reachmd.com/ma-issues-index/2025-mar-apr/revolutionizing-aesthetic-medicine-and-dermatology-with-artificial-intelligence/36064/This article explores the possibilities of AI and how it can be ethically utilized to enhance aesthetic medicine and marketing to grow one’s practice to its maximum potential.The IL-36 Connection: Immunology’s Role in GPP Pathogenesis and Therapy
https://reachmd.com/programs/cme/il-36-gpp-pathogenesis-therapy/54775/Generalized pustular psoriasis (GPP) can look familiar but missing it can have serious consequences. Uncover how IL-36 signaling and immune dysregulation shape disease presentation, progression, and treatment response. You’ll learn to distinguish GPP from other neutrophilic dermatoses using clinicalDecoding IgA Nephropathy: From Suspicion to Solution
https://reachmd.com/programs/cme/decoding-iga-nephropathy-from-suspicion-to-solution/26634/Examine mechanisms, diagnostics, and novel therapies in IgA nephropathy (IgAN) to inform evidence-based, personalized treatment plans.IBD Masterclass: Foundations of Pathophysiology and Targeted Therapy
https://reachmd.com/programs/cme/ibd-masterclass-foundations-of-pathophysiology-and-targeted-therapy/49149/Examine the biological mechanisms underlying IBD, including genetic, microbial, environmental, and immune pathways that inform therapeutic targets.Inside the Cataracts Studio: Advanced Fluidics, Ergonomics, and Techniques for Complex Cases - Introducing Robotic SLACS
https://reachmd.com/programs/cme/inside-the-cataracts-studio-advanced-fluidics-ergonomics-and-techniques-for-complex-cases-introducing-robotic-slacs/33177/Explore SLACS for cataract surgery, which features a robotic femtosecond laser integrated into the operating suite that can be utilized for complex cases.Understanding the MOA of NEMLUVIO®: Targeting IL-31 Signaling in Neuroimmune Skin Diseases
https://reachmd.com/videos/nemluvio-peer-network/understanding-the-moa-of-nemluvio-targeting-il-31-signaling-in-neuroimmune-skin-diseases/37128/Watch Dr Peter Lio as he explains the role of IL-31, a key neuroimmune cytokine, in AD and PN and provides an in depth overview of the mechanism of action for NEMLUVIO®.Hypertrophic Cardiomyopathy: Overcoming Practical Barriers to Treatment in the Era of Myosin Inhibitors
https://reachmd.com/clinical-practice/cardiology/hypertrophic-cardiomyopathy-overcoming-practical-barriers-to-treatment-in-the-era-of-myosin-inhibitors/56414/Dive into practical barriers to myosin inhibitor use in HCM and learn strategies to support timely initiation and access for eligible patients.Insights for Postmenopausal Osteoporosis Patients at Very High Risk of Fracture
https://reachmd.com/programs/medical-industry-feature/postmenopausal-osteoporosis-high-fracture-risk/27132/Starting with the presence of a prior fracture, advancing age, and bone mineral density, there are numerous factors that increase the risk of fracture in postmenopausal women.1 But despite these common predictors, treatment rates of osteoporosis in postmenopausal women have consistently remained lowHitting the Target in Atopic Dermatitis: Interdisciplinary Team Training for Leveraging IL-13 Inhibitors to Address the Burden of Disease
https://reachmd.com/programs/cme/hitting-the-target-in-atopic-dermatitis-interdisciplinary-team-training-for-leveraging-il-13-inhibitors-to-address-the-burden-of-disease/54437/On-demand webcast on the role of interleukin (IL)-13 in atopic dermatitis pathophysiology and strategies for leveraging IL-13 inhibitors to address disease burden and improve patient outcomes.From Beta-Blockers to Myosin Inhibitors: Initial Decision-Making in Obstructive HCM
https://reachmd.com/programs/cme/from-beta-blockers-to-myosin-inhibitors-initial-decision-making-in-obstructive-hcm/54843/Explore how cardiac myosin inhibitors are reshaping obstructive HCM management, from unmet needs to individualized, evidence-based treatment.